While there are many different treatment options for patients with obesity, a universally accepted care model does not exist. AMGA Foundation aimed to change this through its Obesity Care Model Collaborative (OCMC), a three-year initiative that provided a framework for expanded work on this disease. Through this Collaborative, 10 of the nation's top performing medical groups and health systems came together to share strategies for treating obesity. Participant c ase studies capture interventions used by each group to improve care for patients with obesity, such as establishing obesity clinics, employing nurse navigators, enhancing IT solutions, and leveraging patient champions. Read through the case studies for more details on lessons learned from this program.

Learn More

Cardiovascular diseases are the leading cause of death in the United States, and atherosclerotic disease, including coronary and peripheral artery disease (CAD/PAD), costs the U.S. billions of dollars annually. Last month, Janssen Pharmaceuticals, Inc., presented a webinar that provided an overview of CAD/PAD, reviewed current guidelines for management, and discussed the use of targeted risk assessment tools to identify high-risk patients. Keep an eye out for the webinar recording to learn more about what opportunities exist for improvement in care for CAD/PAD patients and strategies to better identify high-risk CAD/PAD patients.